Open Market Insiders Trades - Sells only
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
LLY
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct | 2,629 Reduced 0.0% |
$2,852,911
$1085.17 p/Share
|
Dec 24
2025 |
|
NN
|
Susan Brasse Insley
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 2,370 Reduced 1.81% |
$40,432
$17.06 p/Share
|
Dec 24
2025 |
|
RKT
|
Matthew Rizik
Director |
SELL
Open market or private sale
|
Direct | 2,500 Reduced 0.23% |
$48,600
$19.44 p/Share
|
Dec 24
2025 |
|
PATH
|
Daniel Dines
CEO and Chairman |
SELL
Open market or private sale
|
Direct | 45,000 Reduced 0.16% |
$760,950
$16.91 p/Share
|
Dec 24
2025 |
|
DVAX
|
David F Novack
President & COO |
SELL
Open market or private sale
|
Direct | 30,000 Reduced 21.21% |
$464,700
$15.49 p/Share
|
Dec 24
2025 |
|
PLNHF
|
Chris Wren
VP of Operations |
SELL
Open market or private sale
|
Direct | 30,000 Reduced 0.75% |
$6,900
$0.23 p/Share
|
Dec 24
2025 |
|
CRDO
|
James Laufman
Chief Legal Officer, Secretary |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 4.45% |
$1,500,000
$150.0 p/Share
|
Dec 24
2025 |
|
LUCY
|
Vladimir Galkin |
SELL
Open market or private purchase
|
Direct | 928 Reduced 0.1% |
$1,215
$1.31 p/Share
|
Dec 24
2025 |
|
VICR
|
Patrizio Vinciarelli
Chairman and CEO |
SELL
Open market or private sale
|
Direct | 12,400 Reduced 0.13% |
$1,351,600
$109.0 p/Share
|
Dec 24
2025 |
|
CSAI
|
Sheldon Richard Bentley
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 25,000 Reduced 14.29% |
$25,500
$1.02 p/Share
|
Dec 24
2025 |
|
MFH
|
Wilfred Zhong Kei Daye
CSO |
SELL
Open market or private sale
|
Direct | 1,500 Reduced 2.57% |
$9,195
$6.13 p/Share
|
Dec 24
2025 |
|
VSTM
|
Daniel Calkins
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 80 Reduced 0.07% |
$628
$7.86 p/Share
|
Dec 24
2025 |
|
PKBK
|
Elizabeth A Milavsky
Director |
SELL
Open market or private sale
|
Direct | 10,981 Reduced 23.74% |
$271,340
$24.71 p/Share
|
Dec 24
2025 |
|
PB
|
Ned S Holmes |
SELL
Open market or private sale
|
Indirect | 600 Reduced 0.0% |
$42,588
$70.98 p/Share
|
Dec 24
2025 |
|
PB
|
Ned S Holmes |
SELL
Open market or private sale
|
Direct | 500 Reduced 0.58% |
$35,480
$70.96 p/Share
|
Dec 24
2025 |
|
MPWR
|
Victor K Lee |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 3.38% |
$952,180
$952.18 p/Share
|
Dec 24
2025 |
|
KELYA
|
Leslie A Murphy
Director |
SELL
Open market or private sale
|
Direct | 47 Reduced 0.15% |
$400
$8.52 p/Share
|
Dec 24
2025 |
|
NXGL
|
Adam R. Levy
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 4,000 Reduced 1.11% |
$6,280
$1.57 p/Share
|
Dec 24
2025 |
|
CRCT
|
Arora Ashish
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 20,833 Reduced 0.49% |
$102,915
$4.94 p/Share
|
Dec 24
2025 |
|
CTSH
|
Michael Patsalos Fox
Director |
SELL
Open market or private sale
|
Direct | 4,000 Reduced 9.59% |
$341,200
$85.3 p/Share
|
Dec 24
2025 |
|
BRLIR
|
Anastasiia Kotaieva |
SELL
Open market or private sale
|
Indirect | 70,000 Reduced 0.0% |
$319,900
$4.57 p/Share
|
Dec 23
2025 |
|
CLNN
|
Chidozie Ugwumba
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 6,831 Reduced 0.0% |
$42,830
$6.27 p/Share
|
Dec 23
2025 |
|
ALZN
|
Milton C Ault Iii |
SELL
Open market or private sale
|
Direct | 1,851 Reduced 100.0% |
$3,831
$2.07 p/Share
|
Dec 23
2025 |
|
WISA
|
Nathaniel T Bradley
Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 11,987 Reduced 0.0% |
$11,028
$0.92 p/Share
|
Dec 23
2025 |
|
WISA
|
Nathaniel T Bradley
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 31,031 Reduced 0.36% |
$28,548
$0.92 p/Share
|
Dec 23
2025 |
|
WISA
|
Stanley Mbugua
Officer |
SELL
Open market or private sale
|
Direct | 14,720 Reduced 1.36% |
$13,542
$0.92 p/Share
|
Dec 23
2025 |
|
NNE
|
Kenny Joe Yung Yu
Director |
SELL
Open market or private sale
|
Direct | 40,000 Reduced 72.73% |
$1,304,800
$32.62 p/Share
|
Dec 23
2025 |
|
NNE
|
Tsun Yee Law
Director |
SELL
Open market or private sale
|
Direct | 55,000 Reduced 42.31% |
$1,794,099
$32.62 p/Share
|
Dec 23
2025 |
|
WISA
|
Brett Moyer
Director |
SELL
Open market or private sale
|
Direct | 49,016 Reduced 1.29% |
$45,094
$0.92 p/Share
|
Dec 23
2025 |
|
NNE
|
Diane Elizabeth Hare
Director |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 100.0% |
$652,000
$32.6 p/Share
|
Dec 23
2025 |
|
FLYW
|
Phillip John Riese |
SELL
Open market or private sale
|
Direct | 367 Reduced 0.16% |
$5,505
$15.0 p/Share
|
Dec 23
2025 |
|
CTNM
|
Daniel S. Lorrain
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 4,170 Reduced 2.47% |
$50,999
$12.23 p/Share
|
Dec 23
2025 |
|
RKLB
|
Edward H. Frank
Director |
SELL
Open market or private sale
|
Direct | 2,500 Reduced 1.72% |
$193,475
$77.39 p/Share
|
Dec 23
2025 |
|
ALMU
|
Mark N. Tompkins
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 0.72% |
$223,050
$14.87 p/Share
|
Dec 23
2025 |
|
WHF
|
John Paul Volpe
Director |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 100.0% |
$6,820
$6.82 p/Share
|
Dec 23
2025 |
|
ROIV
|
Eric Venker
President & Immunovant CEO |
SELL
Open market or private sale
|
Direct | 200,000 Reduced 11.04% |
$4,490,000
$22.45 p/Share
|
Dec 23
2025 |
|
ROIV
|
Richard Pulik
CFO |
SELL
Open market or private sale
|
Direct | 406,731 Reduced 62.95% |
$9,118,909
$22.42 p/Share
|
Dec 23
2025 |
|
AJG
|
Christopher E Mead
VICE PRESIDENT |
SELL
Open market or private sale
|
Direct | 4,000 Reduced 18.76% |
$1,032,440
$258.11 p/Share
|
Dec 23
2025 |
|
JCTCF
|
Community Foundation Oregon
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 1,104 Reduced 0.13% |
$2,484
$2.25 p/Share
|
Dec 23
2025 |
|
MAX
|
Eugene Nonko
Director |
SELL
Open market or private sale
|
Direct | 5,400 Reduced 0.52% |
$68,472
$12.68 p/Share
|
Dec 23
2025 |
|
MAX
|
Eugene Nonko
Director |
SELL
Open market or private sale
|
Indirect | 6,700 Reduced 0.0% |
$84,956
$12.68 p/Share
|
Dec 23
2025 |
|
PPTA
|
Robert Alan Dean
Director |
SELL
Open market or private sale
|
Direct | 6,490 Reduced 21.63% |
$178,799
$27.55 p/Share
|
Dec 23
2025 |
|
UWMC
|
Ishbia Mat
President and CEO |
SELL
Open market or private sale
|
Indirect | 402,483 Reduced 0.0% |
$1,891,670
$4.7 p/Share
|
Dec 23
2025 |
|
MAX
|
Steven Yi
Director |
SELL
Open market or private sale
|
Direct | 8,000 Reduced 0.28% |
$101,440
$12.68 p/Share
|
Dec 23
2025 |
|
LION
|
Michael Raymond Burns
Vice Chair |
SELL
Open market or private sale
|
Direct | 21,748 Reduced 0.71% |
$195,949
$9.01 p/Share
|
Dec 23
2025 |
|
ACEL
|
Derek Harmer
Chief Compliance Officer |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 2.44% |
$57,500
$11.5 p/Share
|
Dec 23
2025 |
|
GDYN
|
Leonard Livschitz
CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 0.35% |
$93,300
$9.33 p/Share
|
Dec 23
2025 |
|
SCHW
|
Jonathan S Beatty
MD, Head of Advisor Services |
SELL
Open market or private sale
|
Indirect | 2,000 Reduced 0.0% |
$204,020
$102.01 p/Share
|
Dec 23
2025 |
|
PCVX
|
Elvia Cowan
SVP, FINANCE |
SELL
Open market or private sale
|
Direct | 11,623 Reduced 44.44% |
$556,974
$47.92 p/Share
|
Dec 23
2025 |
|
PLMR
|
Jon Christianson
President |
SELL
Open market or private sale
|
Direct | 1,691 Reduced 2.76% |
$235,894
$139.5 p/Share
|
Dec 23
2025 |